Advanced Wireless Sensors for Neonatal Care in the Delivery Room

Recruiting N/A Interventional Study
Sudden Unexplained Infant Death Apnea of Newborn Newborn Morbidity Newborn Asphyxia Birth Outcome, Adverse Birth Asphyxia Pregnancy Related Newborn; Vitality ECG Electrode Site Reaction Infant ALL Infant Death Infant, Newborn, Diseases Infant Apnea Infant Conditions Parents Delivery Problem for Fetus Delivery Complication
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
35 Weeks – 42 Weeks
Sex
Any
Study type
Interventional
Purpose
Other
Participants needed
600 (estimated)
Sponsor
Guilherme Sant'Anna, MD · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
The goals of this observational study is to assess whether a new advanced wireless skin sensor vital sign monitoring system can effectively monitor the vital signs of healthy newborn infants (≥ 35 weeks gestational age). The main aims of this Study are to: 1. Assess feasibility 2. Evaluate safety 3. Determine accuracy of the wireless monitoring system, compared to the standard of care wired vital…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion criteria: 1. Newborns ≥35 weeks (gestational age) 2. Newborns determined to be clinically stable at delivery 3. Newborns with no skin abnormalities Exclusion criteria: 1. Newborns ≤ 35 weeks (gestational age) 2. Newborns determined to not be clinically stable at delivery 3. Newborns wit…
Contacts

Guilherme Sant´Anna, MD, PhD

514-934-1934

guilherme.santanna@mcgill.ca

CONTACT

Alyssa Maximov, BSc

514-934-1934

alyssa.maximov@muhc.mcgill.ca

CONTACT